Chronic benzodiazepine administration alters hippocampal CA1 neuron excitability: NMDA receptor function and expression11Portions of this manuscript have been published in abstract form: Society for Neuroscience Abstracts 25:391.5, 1999 and 27:262.3, 2001.
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Rats are tolerant to benzodiazepine (BZ) anticonvulsant actions two days after ending one-week administration of the BZ, flurazepam (FZP). Concurrently, GABA(A) receptor-mediated inhibition is reduced and AMPA receptor-mediated excitation is selectively enhanced in CA1 pyramidal neurons in hippocampal slices. In the present study, the effects of chronic FZP exposure on NMDA receptor (NMDAR) currents were examined in CA1 pyramidal neurons in hippocampal slices and following acute dissociation. In CA1 neurons from chronic FZP-treated rats, evoked NMDAR EPSC amplitude was significantly decreased (52%) in slices, and the maximal current amplitude of NMDA-induced currents in dissociated neurons was also significantly reduced (58%). Evoked NMDAR EPSCs were not altered following acute desalkyl-FZP treatment. Using in situ hybridization and immunohistochemical techniques, a selective reduction in NR2B subunit mRNA and protein expression was detected in the CA1 and CA2 regions following FZP treatment. However, total hippocampal NMDAR number, as assessed by autoradiography with the NMDAR antagonist, [(3)H]MK-801, was unchanged by FZP treatment. These findings suggest that reduced NMDAR-mediated currents associated with chronic BZ treatment may be related to reduced NR2B subunit-containing NMDARs in the CA1 and CA2 regions. Altered NMDAR function and expression after chronic BZ exposure may contribute to BZ anticonvulsant tolerance or dependence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, another study showed decreases in hippocampal NR2B subunits after chronic flurazepam treatment, even though the total amount of NMDA receptors was unchanged [127].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [127]
Citations
Cites
Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535 · cited 5×
“In hippocampus, NR1, NR2A and NR2B subunit mRNAs ( Monyer et al., 1994 ) and proteins (Petralia et al., 1994a, 1994b) are abundantly expressed suggesting that NMDARs in hippocampal neurons likely also consist of di- and triheteromeric complexes of NR1 with NR2 subunits.”
BackgroundInfluentialMacdonald, R. L., & Olsen, R. W. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.003033 · Cited by 1,975 · cited 2×
“BZs increase GABA affinity and thereby increase the frequency of Cl channel opening, potentiating GABAR-mediated inhibitory responses in the central nervous system ( Macdonald and Olsen, 1994 ).”
BackgroundChanging subunit composition of heteromeric NMDA receptors during development of rat cortex
Sheng, M., Cummings, J., Roldan, L. A., Jan, Y. N., & Jan, L. Y. (1994) · Nature · doi:10.1038/368144a0 · Cited by 1,377 · cited 1×
“Co-immunoprecipitation studies of cortical membranes suggests that native adult forebrain NMDARs are composed of NR1/NR2A, NR1/NR2B and NR1/NR2A/NR2B complexes ( Sheng et al., 1994; Blahos and Wenthold, 1996; Luo et al., 1997) with a signifi cant proportion (up to 50%) of complexes containing NR1/NR2A/NR2B (Luo et al.…”
BackgroundPetralia, R., Yokotani, N., & Wenthold, R. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-02-00667.1994 · Cited by 850
Ionic Mechanisms of Neuronal Excitation by Inhibitory GABA A Receptors
Staley, K. J., Soldo, B. L., & Proctor, W. R. (1995) · Science · doi:10.1126/science.7638623 · Cited by 781
Functional and Pharmacological Differences Between Recombinant N-Methyl-d-Aspartate Receptors
Vicini, S., Wang, J. F., Li, J. H., Zhu, W. J., Wang, Y. H., Luo, J. H., Wolfe, B. B., & Grayson, D. R. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.79.2.555 · Cited by 674
Feed‐forward dendritic inhibition in rat hippocampal pyramidal cells studied in vitro
Alger, B. E., & Nicoll, R. A. (1982) · The Journal of Physiology · doi:10.1113/jphysiol.1982.sp014255 · Cited by 527
Petralia, R., Wang, Y., & Wenthold, R. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-10-06102.1994 · Cited by 481
Luo, J., Wang, Y., Yasuda, R. P., Dunah, A. W., & Wolfe, B. B. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.1.79 · Cited by 401
Kew, J. N. C., Richards, J. G., Mutel, V., & Kemp, J. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-06-01935.1998 · Cited by 226
Cited by
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965
Vinkers, C. H., & Olivier, B. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/416864 · Cited by 195
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Panhelainen, A. E., Möykkynen, T. P., & Korpi, E. R. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.89 · Cited by 119
GABAA receptor subtypes and benzodiazepine use, misuse, and abuse
Engin, E. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1060949 · Cited by 95
Metadata
- Authors
- Van Sickle, B. J., Cox, A. S., Schak, K., John Greenfield, L., & Tietz, E. I.
- Corresponding author
- Tietz, E.I
- ORCID
- Schak, K
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2002-09
- Volume
- 43
- Issue
- 4
- Pages
- 595-606
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2169996562
- Cited by
- 33
- References
- 33
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 1 · 2018: 1 · 2016: 3 · 2015: 1 · 2014: 1 · 2013: 1 · 2012: 2
- FWCI
- 0.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Neuropharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Drug Abuse (R01-DA0475, F30-DA0604)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- flurazepam, NMDA receptor, NR2B subunit, CA1 pyramidal neurons, neuronal excitability, benzodiazepine dependence, NMDA receptor currents, GABAA inhibition
- MeSH terms
- Animals, Autoradiography, Benzodiazepines, Electrophysiology, Evoked Potentials, Flunitrazepam, Hippocampus, Image Processing, Computer-Assisted, Immunohistochemistry, Indicators and Reagents, Male, Synaptic Transmission, Neurons, RNA, Messenger, Receptors, N-Methyl-D-Aspartate, N-Methylaspartate, Dizocilpine Maleate, Rats, Sprague-Dawley, In Situ Hybridization, Pyramidal Cells, Excitatory Amino Acid Antagonists, GABA Modulators, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic benzodiazepine administration alters hippocampal CA1 neuron excitability: NMDA receptor function and expression11Portions of this manuscript have been published in abstract form: Society for Neuroscience Abstracts 25:391.5, 1999 and 27:262.3, 2001. https://app.cochat.ai/papers/10.1016/s0028-3908(02)00152-1
- The paper
- Van Sickle, B. J., Cox, A. S., Schak, K., John Greenfield, L., & Tietz, E. I. (2002). Chronic benzodiazepine administration alters hippocampal CA1 neuron excitability: NMDA receptor function and expression11Portions of this manuscript have been published in abstract form: Society for Neuroscience Abstracts 25:391.5, 1999 and 27:262.3, 2001. Neuropharmacology. https://doi.org/10.1016/s0028-3908(02)00152-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.